Compounds > 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea
Page last updated: 2024-08-22

1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea and Benign Neoplasms

1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea has been researched along with Benign Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benjamin, RS; Bodey, GP; Burgess, MA; Leavens, M; Stewart, DJ; Valdivieso, M1
Casper, ES; Gordon, C; Gralla, RJ; Kalman, LA; Kris, MG; Woodcock, TM1
Levin, VA; Liu, J; Weinkam, RJ1
Bruno, S; Penta, JS; Poster, DS1
Friedman, MA1
Korsmeyer, SJ; Luc, PV; Rahman, A; Schein, PS; Smith, FP; Woolley, PV1

Trials

1 trial(s) available for 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea and Benign Neoplasms

ArticleYear
Comparative pharmacokinetics of 1-(2-chloroethyl)-3-(2,6-dioxo-1-piperidyl)-1-nitrosourea in rats and patients and extrapolation to clinical trials.
    Cancer research, 1981, Volume: 41, Issue:9 Pt 1

    Topics: Animals; Carmustine; Clinical Trials as Topic; Drug Evaluation; Gas Chromatography-Mass Spectrometry; Humans; Kinetics; Mustard Compounds; Neoplasms; Nitrosourea Compounds; Rats

1981

Other Studies

5 other study(ies) available for 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea and Benign Neoplasms

ArticleYear
Phase I study of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (NSC 95466) in adults with solid tumors.
    Cancer research, 1980, Volume: 40, Issue:10

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Brain Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Glioblastoma; Glioma; Humans; Hypotension; Male; Middle Aged; Mustard Compounds; Nausea; Neoplasms; Nitrosourea Compounds; Thrombocytopenia

1980
Phase I trial of PCNU.
    Cancer treatment reports, 1983, Volume: 67, Issue:11

    Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Drug Evaluation; Female; Glioma; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasms; Nitrosourea Compounds; Thrombocytopenia

1983
PCNU: a new nitrosourea in clinical oncology.
    American journal of clinical oncology, 1982, Volume: 5, Issue:1

    Topics: Animals; Antineoplastic Agents; Bone Marrow; Drug Evaluation; Drug Evaluation, Preclinical; Half-Life; Humans; Kinetics; Mustard Compounds; Neoplasms; Nitrosourea Compounds

1982
PCNU Phase I study in the North California Oncology Group.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1981, Volume: 76

    Topics: Antineoplastic Agents; Drug Evaluation; Humans; Mustard Compounds; Neoplasms; Nitrosourea Compounds

1981
Phase I trial and clinical pharmacology of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea.
    Cancer research, 1981, Volume: 41, Issue:10

    Topics: Anemia; Drug Evaluation; Half-Life; Humans; Kinetics; Leukopenia; Middle Aged; Mustard Compounds; Neoplasms; Nitrosourea Compounds; Protein Binding; Thrombocytopenia

1981